Latest Security News

Centuria Office REIT reported its strongest quarterly leasing performance to date, signing over 23,400 sqm across key properties while maintaining solid occupancy and reaffirming its FY26 financial guidance.

Wrkr Ltd has reported a strong start to FY26 with its third consecutive quarter of positive operating cash flow and a successful $15 million capital raise, positioning the fintech for accelerated growth ahead of major client launches.

Lithium Universe Limited has secured exclusive rights to a breakthrough silver extraction technology from Macquarie University, promising high-purity silver recovery from solar panels while preserving valuable silicon wafers. This innovation complements their existing recycling and lithium refining strategies in North America.

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

Astron Limited has achieved major milestones for its Donald Rare Earth and Mineral Sands Project, including government recognition and conditional financing, setting the stage for a Final Investment Decision by year-end.

Strata Minerals has exercised its option to acquire 100% of the Zelica Gold Project in Western Australia’s Laverton Province, aiming to fast-track exploration with drilling planned for late 2025. The project boasts historical high-grade gold intercepts and a granted mining licence, positioning Strata for near-term resource development.

Global Lithium Resources Limited has achieved major milestones this quarter with a Native Title Mining Agreement and Mining Lease granted for its Manna Lithium Project, while exploration at Marble Bar reveals encouraging signs of a large gold system.

Turaco Gold has updated its Afema Project Mineral Resource Estimate, increasing gold resources to over 4 million ounces with new deposits and ongoing drilling promising further growth.

Harmoney has reaffirmed its FY26 profit guidance, aiming for a $12 million cash NPAT, while unveiling a new secured auto loan product designed to disrupt the car finance market.

Paradigm Biopharmaceuticals has initiated dosing in its pivotal Phase 3 trial for knee osteoarthritis pain, backed by a strong cash position and strategic portfolio expansion. The company targets accelerated recruitment and a mid-2026 interim analysis.

Terragen Holdings expands its probiotic product range into beef and lamb feedlots, secures key international approvals, and progresses large-scale trials while maintaining a $3 million cash reserve.

L1 Group has successfully completed a $286 million institutional placement and a $19 million share sale, positioning itself for accelerated growth and strategic expansion. A follow-up share purchase plan aims to raise an additional $25 million from existing shareholders.